ArticleIEEE journal of biomedical and health informatics2025
Longitudinal Alzheimer's Disease Progression Prediction With Modality Uncertainty and Optimization of Information Flow.
Article in IEEE journal of biomedical and health informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Novel approach to early prediction of alzheimer's disease progression using integrated deep regulatory genetic neural network and optimized deep belief networks.Scientific reports · 2026Article
- MSML-DenseXmer: harnessing vision transformers through integration with novel dense networks for medical image fusion.Scientific reports · 2026Article
- CAHA-Net: A novel MR image classification model based on DenseNet incorporating coordinate attention and hybrid augmentation.Scientific reports · 2026Article
- Design of a configurable SoC for Alzheimer's disease detection based on multimodal signals.BMC bioinformatics · 2026Article
- An attention-augmented multimodal classification of alzheimer's disease and parkinson's disease vs healthy controls using MRI, EEG, and SNP data.Scientific reports · 2026Article
- Intra-scale interaction and cross-scale fusion network for detecting the progression of neurodegeneration in Alzheimer's disease.Scientific reports · 2025Article
- Deep multimodal learning for domain-level cognitive decline prediction in Alzheimer's disease.Frontiers in artificial intelligence · 2025Article
- A lightweight triple-modal fusion network for progressive mild cognitive impairment prediction in Alzheimer's disease.Frontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is a global neurodegenerative disorder that affects millions of individuals worldwide. Actual AD imaging datasets challenge the construction of reliable longitudinal models owing to imaging modality uncertainty. In addition, they are still unable to retain or obtain important information during disease progression from previous to followup time points. For example, the output values of current gates in recurrent models should be close to a specific value that indicates the model is uncertain about retaining or forgetting information. In this study, we propose a model which can extract and constrain each modality into a common representation space to capture intermodality interactions among different modalities associated with modality uncertainty to predict AD progression. In addition, we provide an auxiliary function to enhance the ability of recurrent gate robustly and effectively in controlling the flow of information over time using longitudinal data. We conducted comparative analysis on data from the Alzheimer's Disease Neuroimaging Initiative database. Our model outperformed other methods across all evaluation metrics. Therefore, the proposed model provides a promising solution for addressing modality uncertainty challenges in multimodal longitudinal AD progression prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.